BioSpace News Archive

Fast, reversible oxygen transport with minimal volume change is a key requirement for energy-efficient solid oxide fuel cells (SOFCs).

Greenbrook TMS Inc. today announced that it has (i) completed a non-brokered private placement of common shares of the Company for aggregate gross proceeds of approximately US$6.25 million.

Oxurion NV, announces the below information, following the issuance of 19,013,817 new ordinary shares on March 22, 2023, for a total amount of EUR 200,000, as the result of the conversion of 8 convertible bonds, pursuant to the Capital Commitment entered into with Atlas Special Opportunities, LLC.

Jaguar Health, Inc. announced that the company investor webcast scheduled for Monday, March 27, 2023 to review fourth-quarter 2022 financials and provide corporate updates will now take place at 8:00 a.m. Eastern Daylight Time instead of 8:30 a.m.

Bio-Path Holdings, Inc. (NASDAQ: BPTH) today announced that it will host a live conference call and audio webcast on Friday, March 31, 2023 at 8:30 a.m. ET to report financial results for the fourth quarter and full year ended December 31, 2022 and to provide a business overview.

Cutera, Inc. announced that it received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC on March 21, 2023 indicating that the Company is not currently in compliance with Nasdaq’s Listing Rules due to the Company’s inability to timely file its Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission.

Akebia Therapeutics, Inc. announced that it has filed a revised definitive proxy statement with the Securities and Exchange Commission (SEC) in connection with a special meeting (Special Meeting) of stockholders.

Vaccitech plc today announced its financial results for year end 2022 and an overview of the Company’s progress.

Impel Pharmaceuticals Inc. today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update.

Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast.